Weaker Demand for Older CF Treatments Weaker Demand for Older CF Treatments

Vertex Pharmaceuticals missed Wall Street estimates for third-quarter sales on Monday, hurt by weaker-than-expected demand for its older cystic fibrosis treatments.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
More News: Cystic Fibrosis | Health